A fluorescence assay for rapid detection of ligand binding affinity to HIV-1 gp41

Biological Chemistry

Volumn 387, Issue 4, 2006, Pages 477-483

  Gochin, Miriam ^a,b   Savage, Ryan ^c   Hinckley, Spencer ^c   Cai, Lifeng ^a  

^a Touro University California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Fluorescence; Fusion inhibitors; gp41 peptides; High throughput screening; Metal ion ligation

Indexed keywords

FERROUS ION; GLYCOPROTEIN GP 41; PEPTIDE; PROTEIN INHIBITOR; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CORRELATION ANALYSIS; DISSOCIATION CONSTANT; FLUORESCENCE ANALYSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HYDROPHOBICITY; LIGAND BINDING; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION;

AMINO ACID SEQUENCE; ANTI-HIV AGENTS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HIV ENVELOPE PROTEIN GP41; HYDROPHOBICITY; LIGANDS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; SEQUENCE ANALYSIS, PROTEIN;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33645760751     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.063     Document Type: Article

References (18)

1. Caffrey, M., Cai, M., Kaufman, J., Stahl, S.J., Wingfield, P.T., Covell, D.G., Gronenborn, A.M., and Clore, G.M. (1998). Three-dimensional solution structure of the 44-kDa ectodomain of SIV gp41. EMBO J. 17, 4572-4584.
2. Case, M.A. and McLendon, G.L. (2000). A virtual library approach to investigate protein folding and internal packing. J. Am. Chem. Soc. 122, 8089-8090.
3. Chan, D.C., Chutkowski, C.T., and Kim, P.S. (1998). Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target. Proc. Natl. Acad. Sci. USA 95, 15613-15617.
4. Chen, Y.-H., Xiao, Y., and Dierich, M.P. (2000). HIV-1 gp41, role in HIV entry and prevention. Immunobiology 201, 308-316.
5. Eckert, D.M., Malashkevich, V.N., Hong, L.H., Carr, P.A., and Kim, P.S. (1999). Inhibiting HIV-1 entry, discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket. Cell 99, 103-115.
6. Gochin, M., Khorosheva, V., and Case, M.A. (2002). Structural characterization of a paramagnetic metal-ion-assembled three-stranded α-helical coiled coil. J. Am. Chem. Soc. 124, 11018-11028.
7. Gochin, M., Guy, R.K., and Case, M.A. (2003). A metallopeptide assembly of the HIV-1 gp41 coiled coil is an ideal receptor in fluorescence detection of ligand binding. Angew. Chem. Int. Ed. 42, 5325-5328.
8. Jiang, S., Lin, K., Zhang, L., and Debnath, A.K. (1999). A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody. J. Virol. Methods 80, 85-96.
9. Kilgore, N.R., Salzwedel, K., Reddick, M., Allaway, G.P., and Wild, C.T. (2003). Direct evidence that C-peptide inhibitors of human immunodeficiency virus type 1 entry bind to the gp41 N-helical domain in receptor-activated viral envelope. J. Virol. 77, 7669-7672.
10. nd Edition (New York/London: Plenum Press), pp. 237-265.
11. Liu, S., Zhao, Q., and Jiang, S. (2003). Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides, applicable for identification of HIV-1 fusion inhibitors. Peptides 24, 1303-1313.
12. Marme, N., Knemeyer, J.-P., Sauer, M., and Wolfrum, J. (2003). Inter- and intramolecular fluorescence quenching of organic dyes by tryptophan. Bioconjug. Chem. 14, 1133-1139.
13. Mo, H., Konstantinidis, A.K., Stewart, K.D., Dekhtyar, T., Ng, T., Swift, K., Matayoshi, E.D., Kati, W., Kohlbrenner, W., and Molla, A. (2004). Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction. Virology 329, 319-327.
14. Ogihara, N.L., Weiss, M.S., Degrado, W.F., and Eisenberg, D. (1997). The crystal structure of the designed trimeric coiled coil coil-VaLd, implications for engineering crystals and supramolecular assemblies. Protein Sci. 6, 80-88.
15. Otaka, A., Nakamura, M., Daisuke, N., Kodama, E., Uchiyama, S., Nakamura, H., Kobayashi, Y., Matsuoka, M., and Fujii, N. (2002). Remodelling of gp41-C34 peptide leads to highly effective inhibitors of the fusion of HIV-1 with target cells. Angew. Chem. Int. Ed. 41, 2938-2939.
16. Root, M. and Steger, H. (2004). HIV-1 gp41 as a target for viral entry inhibition. Curr. Pharm. Des. 10, 1805-1825.
17. Sia, S.K., Carr, P.A., Cochran, A.G., Malashkevich, V.N., and Kim, P.S. (2002). Short constrained peptides that inhibit HIV-1 entry. Proc. Natl. Acad. Sci. USA 99, 14664-14669.
18. Wild, C.T., Shugars, D.C., Greenwell, T.K., McDanal, C.B., and Matthews, T.J. (1994). Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91, 9770-9774.